Showing results (391-400 of 560) with videos related to
Sort By:
Pageof 56
Journal of Gastroenterology|March 22, 2017
Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitisYasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Ectopic CD40 ligand expression on B cells triggers intestinal inflammationTakahiro Kawamura, Takanori Kanai, Taeko Dohi, et al.Journal of Crohn'S & Colitis|June 21, 2011
Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from JapanMakoto Naganuma, Reiko Kunisaki, Naoki Yoshimura, et al.DEN Open|December 21, 2022
Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximabShun Fujiwara, Ami Kawamoto, Maiko Motobayashi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 29, 2019
Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patientSayuri Nitta, Kazuaki Takahashi, Fukiko Kawai-Kitahata, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular cloneNorio Maeda, Mamoru Watanabe, Susumu Okamoto, et al.Journal of Gastroenterology|December 24, 2013
Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitisYasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, et al.Biochemical and Biophysical Research Communications|December 16, 2003
Specific inhibition of hepatitis C virus replication by cyclosporin AMina Nakagawa, Naoya Sakamoto, Nobuyuki Enomoto, et al.Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|January 10, 2017
Surveillance for dysplasia in patients with ulcerative colitis: Discrepancy between guidelines and practiceMasaru Shinozaki, Kiyonori Kobayashi, Reiko Kunisaki, et al.Journal of Gastroenterology and Hepatology|August 19, 2021
Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitisMakoto Naganuma, Kenji Watanabe, Satoshi Motoya, et al.Pageof 56